| New Technologies, Development and Application IV I Karabegović Springer Nature, 2021 | 8 | 2021 |
| In Silico Analysis of Scopoletin Interaction with Potential SARS-CoV-2 Target T Ikanovic, E Sehercehajic, B Saric, N Tomic, R Hadziselimovic | 7 | 2021 |
| In silico analysis of selected components of grapefruit seed extract against SARS-CoV-2 main protease B Saric, N Tomic, A Kalajdzic, N Pojskic, L Pojskic The EuroBiotech Journal 5 (S1), 5-12, 2021 | 3 | 2021 |
| Evaluation of antimicrobial potential of different commercial Grapefruit seed extracts B Saric, I MahmutoviÄ, A Gutalj, A JerkoviÄ Journal of microbiology, biotechnology and food sciences 11 (1), e4213-e4213, 2021 | 2 | 2021 |
| RS17817449 FTO gene variation associated with familial disease burden rather than individual risk for breast cancer B Hasanbegović, BS Medić, E Sokolović, N Tomić, L Pojskić Journal of Health Sciences 13 (2), 98-104, 2023 | | 2023 |
| In vitro assessment of the antioxidative, toxicological and antimicrobial properties of battery of parabens S Katavic, I Cehic, N Zukic, M Mirvic, M Dizdar, A Gutalj, B Saric Medic, ... Drug and Chemical Toxicology, 1-10, 2023 | | 2023 |
| LABORATORIJSKI PRIRUČNIK L Pojskić, N Lojo-Kadrić, J Ramić, N Tomić, B Šarić-Medić | | 2023 |
| ISABS 2022 poster presentations on medical genetics K Vrdoljak Journal of Bioanthropology 2 (1), 2022 | | 2022 |
| CRISPR-Cas u medicini B Šarić, N Tomić, J Ramić, N Lojo-Kadrić, L Pojskić Bilten Udruženja genetičara u Bosni i Hercegovini CRISPR CAS, 47, 2022 | | 2022 |
| Bioinformatika u dizajniranju novih vakcina A Kalajdžić, T Čorbo, N Tomić, B Šarić COVID-19 O genomu SARS-CoV-2 kao izvoru njegove snage i slabosti, 31, 2021 | | 2021 |
| Vakcine protiv COVID-19 (anti-SARS-CoV-2) B Šarić, N Meštrovac COVID-19 O genomu SARS-CoV-2 kao izvoru njegove snage i slabosti, 26, 2021 | | 2021 |
